Clinical Trial: Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Thyroid Cancer
Study Type: INTERVENTIONAL
Official Title: Clinical Study of Aprepitant and Ondansetron Monotherapy or Combination in the Treatment of Postoperative Nausea and Vomiting in Thyroid Carcinoma
Brief Summary:
The vast majority of patients treated prophylactically with "first-line" antiemetics in the 5-hydroxytryptamine (5-HT3) receptor antagonist class still have significant PONV.Combination therapies with different pharmacologic bases have the potential to reduce the incidence of PONV.This study is a multicenter, three-arm, prospective study to evaluate the efficacy and safety of aprepitant and ondansetron, monotherapy or in combination, in the prevention of nausea and vomiting after surgery for thyroid…
Read more